Suzuken Co., Ltd.
General ticker "SZUKF" information:
- Sector: Health Care
- Industry: Medical - Distribution
- Capitalization: $2.3B (TTM average)
Suzuken Co., Ltd. does not follow the US Stock Market performance with the rate: nan%.
Estimated limits based on current volatility of 0.0%: low 30.30$, high 30.30$
Factors to consider:
- Company pays dividends (annually): last record date 2025-09-30, amount 0.34$ (Y1.12%)
- Earnings for 6 months up through Q2 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-03-31 to 2027-03-31
- 2025-03-31 to 2026-03-31 estimated range: [23.69$, 33.52$]
- 2026-03-31 to 2027-03-31 estimated range: [24.23$, 34.39$]
Financial Metrics affecting the SZUKF estimates:
- Positive: with PPE of 10.1 at the end of fiscal year the price was neutral
- Negative: Operating cash flow per share per price, % of -18.87 <= 0.33
- Positive: -3.60 < Operating profit margin, % of 1.55
- Positive: 18.93 < Shareholder equity ratio, % of 36.57 <= 41.86
- Negative: Industry operating cash flow per share per price (median), % of 4.84 <= 5.52
- Positive: Investing cash flow per share per price, % of 5.91 > -0.66
- Positive: 1.87 < Return on assets ratio (scaled to [-100,100]) of 3.00
Short-term SZUKF quotes
Long-term SZUKF plot with estimates
Financial data
| YTD | 2023-03-31 | 2024-03-31 | 2025-03-31 |
|---|---|---|---|
| Operating Revenue | ¥2,314,828.00MM | ¥2,386,493.00MM | ¥2,399,952.00MM |
| Operating Expenses | ¥2,282,223.00MM | ¥2,351,618.00MM | ¥2,362,827.00MM |
| Operating Income | ¥32,605.00MM | ¥34,875.00MM | ¥37,125.00MM |
| Non-Operating Income | ¥-2,011.00MM | ¥7,918.00MM | ¥13,162.00MM |
| Interest Expense | ¥42.00MM | ¥43.00MM | ¥41.00MM |
| R&D Expense | ¥2,952.00MM | ¥0.00MM | ¥0.00MM |
| Income(Loss) | ¥30,594.00MM | ¥42,793.00MM | ¥50,287.00MM |
| Taxes | ¥10,275.00MM | ¥13,793.00MM | ¥15,783.00MM |
| Profit(Loss)* | ¥20,345.00MM | ¥29,016.00MM | ¥34,496.00MM |
| Stockholders Equity | ¥411,208.00MM | ¥416,306.00MM | ¥407,291.00MM |
| Inventory | ¥139,368.00MM | ¥142,356.00MM | ¥153,190.00MM |
| Assets | ¥1,146,097.00MM | ¥1,228,686.00MM | ¥1,113,831.00MM |
| Operating Cash Flow | ¥37,270.00MM | ¥87,216.00MM | ¥-65,079.00MM |
| Capital expenditure | ¥17,742.00MM | ¥15,640.00MM | ¥18,647.00MM |
| Investing Cash Flow | ¥-46,361.00MM | ¥10,350.00MM | ¥20,378.00MM |
| Financing Cash Flow | ¥-26,219.00MM | ¥-31,716.00MM | ¥-35,483.00MM |
| Earnings Per Share** | ¥236.46 | ¥357.87 | ¥454.58 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.